Terms: = Germ cell tumor AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Treatment
60 results:
1. Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma.
Dedeilia A; Lwin T; Li S; Tarantino G; Tunsiricharoengul S; Lawless A; Sharova T; Liu D; Boland GM; Cohen S
Ann Surg Oncol; 2024 Apr; 31(4):2713-2726. PubMed ID: 38158497
[TBL] [Abstract] [Full Text] [Related]
2.
Romano B; Maresca DC; Somma F; Ahmadi P; Putra MY; Rahmawati SI; Chianese G; Formisano C; Ianaro A; Ercolano G
Mar Drugs; 2023 Jun; 21(7):. PubMed ID: 37504902
[TBL] [Abstract] [Full Text] [Related]
3. Novel treatment strategy of targeting epigenetic dysregulation in pancreatic neuroendocrine tumors.
Zhu C; Sandilos G; Williamson J; Emery R; Platoff R; Joneja U; Acharya NK; Lin A; Badach J; Zilberman B; Madzo J; Jelinek J; Zhang P; Hong YK
Surgery; 2023 Apr; 173(4):1045-1051. PubMed ID: 36642656
[TBL] [Abstract] [Full Text] [Related]
4. Exosomal miR-22-3p from Mesenchymal Stem cells Inhibits the Epithelial-Mesenchymal Transition (EMT) of Melanoma cells by Regulating
Chen Y; Fang Y; Li L; Luo H; Cao T; Tu B
Front Biosci (Landmark Ed); 2022 Sep; 27(9):275. PubMed ID: 36224027
[TBL] [Abstract] [Full Text] [Related]
5. The Comparative Experimental Study of Sodium and Magnesium Dichloroacetate Effects on Pediatric PBT24 and SF8628 cell Glioblastoma tumors Using a Chicken Embryo Chorioallantoic Membrane Model and on cells In Vitro.
Damanskienė E; Balnytė I; Valančiūtė A; Lesauskaitė V; Alonso MM; Stakišaitis D
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142368
[TBL] [Abstract] [Full Text] [Related]
6. [Value of tumor growth rate in evaluating the early therapeutic efficacy of neuroendocrine neoplasm].
Zhou YT; Xia YF; Li Y; Zhu YJ; Chi Y; Jiang L
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1000-1006. PubMed ID: 35399019
[No Abstract] [Full Text] [Related]
7. Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data.
El Sharouni MA; Ahmed T; Witkamp AJ; Sigurdsson V; van Gils CH; Nieweg OE; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
Br J Surg; 2021 May; 108(5):550-553. PubMed ID: 34043770
[TBL] [Abstract] [Full Text] [Related]
8. Rare germline variants in the E-cadherin gene cdh1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.
Förster A; Brand F; Banan R; Hüneburg R; Weber CAM; Ewert W; Kronenberg J; Previti C; Elyan N; Beyer U; Martens H; Hong B; Bräsen JH; Erbersdobler A; Krauss JK; Stangel M; Samii A; Wolf S; Preller M; Aretz S; Wiese B; Hartmann C; Weber RG
Acta Neuropathol; 2021 Jul; 142(1):191-210. PubMed ID: 33929593
[TBL] [Abstract] [Full Text] [Related]
9. Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma.
Owen CN; Bai X; Quah T; Lo SN; Allayous C; Callaghan S; Martínez-Vila C; Wallace R; Bhave P; Reijers ILM; Thompson N; Vanella V; Gerard CL; Aspeslagh S; Labianca A; Khattak A; Mandala M; Xu W; Neyns B; Michielin O; Blank CU; Welsh SJ; Haydon A; Sandhu S; Mangana J; McQuade JL; Ascierto PA; Zimmer L; Johnson DB; Arance A; Lorigan P; Lebbé C; Carlino MS; Sullivan RJ; Long GV; Menzies AM
Ann Oncol; 2021 Jul; 32(7):917-925. PubMed ID: 33798657
[TBL] [Abstract] [Full Text] [Related]
10. Molecular Characterization of Appendiceal Goblet cell Carcinoid.
Arai H; Baca Y; Battaglin F; Kawanishi N; Wang J; Soni S; Zhang W; Millstein J; Johnston C; Goldberg RM; Philip PA; Seeber A; Xiu J; Hwang JJ; Shields AF; Marshall JL; Korn WM; Lenz HJ
Mol Cancer Ther; 2020 Dec; 19(12):2634-2640. PubMed ID: 33037134
[TBL] [Abstract] [Full Text] [Related]
11. A SEMA3 Signaling Pathway-Based Multi-Biomarker for Prediction of Glioma Patient Survival.
Valiulyte I; Steponaitis G; Kardonaite D; Tamasauskas A; Kazlauskas A
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036421
[TBL] [Abstract] [Full Text] [Related]
12. Correlation of preoperative seizures with a wide range of tumor molecular markers in gliomas: An analysis of 442 glioma patients from China.
Shen S; Bai Y; Zhang B; Liu T; Yu X; Feng S
Epilepsy Res; 2020 Oct; 166():106430. PubMed ID: 32712511
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-9 regulates the proliferation, migration and invasion of human glioma cells by targeting cdh1.
Liu Y; Guo L
J BUON; 2020; 25(2):1091-1097. PubMed ID: 32521911
[TBL] [Abstract] [Full Text] [Related]
14. The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma.
Kowalik A; Jurkowska M; Mierzejewska E; Ługowska I; Gos A; Szumera-Ciećkiewicz A; Zięba S; Koseła-Paterczyk H; van der Oord J; Dębiec-Rychter M; Szamotulska K; Siedlecki J; Rutkowski P
Melanoma Res; 2020 Aug; 30(4):348-357. PubMed ID: 32073511
[TBL] [Abstract] [Full Text] [Related]
15. Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend.
Braga A; de Souza Hartung Araújo C; Mora PAR; Paulino E; de Melo AC; Velarde GC; Dos Santos Esteves APV; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
Gynecol Oncol; 2020 Mar; 156(3):598-605. PubMed ID: 31928806
[TBL] [Abstract] [Full Text] [Related]
16. A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells.
Beetham H; Chen A; Telford BJ; Single A; Jarman KE; Lackovic K; Luxenburger A; Guilford P
Sci Rep; 2019 Aug; 9(1):12511. PubMed ID: 31467357
[TBL] [Abstract] [Full Text] [Related]
17. Hyperphosphorylation of cdh1 in Glioblastoma Cancer Stem cells Attenuates APC/C
De K; Grubb TM; Zalenski AA; Pfaff KE; Pal D; Majumder S; Summers MK; Venere M
Mol Cancer Res; 2019 Jul; 17(7):1519-1530. PubMed ID: 31036696
[TBL] [Abstract] [Full Text] [Related]
18. Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study.
Mangili G; Cioffi R; Danese S; Frigerio L; Ferrandina G; Cormio G; Rabaiotti E; Scarfone G; Gadducci A; Bergamini A; Pisano C; Candiani M
Gynecol Oncol; 2018 Dec; 151(3):449-452. PubMed ID: 30266260
[TBL] [Abstract] [Full Text] [Related]
19. Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.
Xie C; Xu M; Lu D; Zhang W; Wang L; Wang H; Li J; Ren F; Wang C
Mol Med Rep; 2018 Sep; 18(3):2715-2723. PubMed ID: 30015885
[TBL] [Abstract] [Full Text] [Related]
20. Quantification of total dinutuximab concentrations in neuroblastoma patients with liquid chromatography tandem mass spectrometry.
El Amrani M; Szanto CL; Hack CE; Huitema ADR; Nierkens S; van Maarseveen EM
Anal Bioanal Chem; 2018 Sep; 410(23):5849-5858. PubMed ID: 29938370
[TBL] [Abstract] [Full Text] [Related]
[Next]
